Intellia Therapeutics, Inc. Collaboration Agreements
3 Contracts & Agreements
- Third Amendment to License and Collaboration Agreement by and between Registrant and Regeneron Pharmaceuticals, Inc., dated September 29, 2023 (Filed With SEC on November 9, 2023)
- Letter Agreement (Second Amendment) to License and Collaboration Agreement by and between Registrant and Regeneron Pharmaceuticals, Inc., dated November 22, 2022 (Filed With SEC on November 9, 2023)
- Amendment No. 1, dated May 30, 2020, to the License and Collaboration Agreement, dated April 11, 2016, by and between Intellia Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc (Filed With SEC on June 1, 2020)
